Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Grass Pollen Subcutaneous Immunotherapy: a Double-blind, Placebo-controlled Study in Elderly Patients With an Allergy to Grass Pollen

NCT02440243 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.

NCT NCT02440243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02440243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Grass Pollen Subcutaneous Immunotherapy: a Double-blind, Placebo-controlled Study in Elderly Patients With an Allergy to Grass Pollen
Lead sponsor
Medical University of Silesia
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2014
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergy